KALARIS THERAPEUTICS, INC. (KLRS)
Kalaris to Present at Clinical Trials at the Summit 2026
Kalaris to Present at Clinical Trials at the Summit 2026
Cushman & Wakefield Advises Ericsson On Record 1 Million-Square-Foot HQ Transaction
3 E Network CEO Outlines Strategic Vision for Robotics, Highlighting Silicon Innovation and Edge AI
Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Sleep Number Corporation (NASDAQ: SNBR)
United Community Banks, Inc. Announces Agreement to Sell Equipment Finance Business, Consisting of Navitas Credit Corp. and NLFC Reinsurance Corp., to Funds Managed by Wafra Inc.
CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
Exodus Launches Exodus Markets for Tokenized Assets with Ondo Finance
Sharon AI Announces Six Year Strategic Compute Collaboration with NVIDIA
QXO Announces Early Tender Results of Cash Tender Offers and Consent Solicitations for Any and All of TopBuild Corp.’s 4.125% Senior Notes due 2032 and 5.625% Senior Notes due 2034 and Receipt of Requisite Consents